GLP-1RAs work to stimulate insulin secretion in a glucose-dependent manner, thus carrying a low risk of hypoglycemia
Labs + Consultation 11-panel lab workup (CBC, CMP, thyroid, lipids, A1C, insulin, vitamins) followed by a provider consultation to review your results
Additionally, research indicates that the pancreas can secrete two isoforms of active GLP-1 under metabolic stress 12,13,14
Therefore, it remains unclear whether neuroprotection arises directly from GIP receptor activation or through improved metabolic control
[15] [16] In the brain, GLP-1 receptor activation has been linked with neurotrophic effects including neurogenesis [17] [18] and neuroprotective effects including reduced necrotic [19] and apoptotic [20] [19] signaling, cell death, [21] [22] and dysfunctions
Its safer to slowly taper off the medication under your healthcare providers guidance